MILKY MIST DAIRY · Q2 FY-2027 · PREVIEW

New verticals, margin expansion in focus as Milky Mist enters second listed quarter

Debut quarter showed 44% revenue growth and sharp margin expansion. Q2 will test whether the newly commissioned high-protein and Greek yogurt lines can sustain momentum while gross margins hold steady.

Q2 FY27 results MILKYMISTMilky Mist Dairy Food Ltd24 Oct 2026 · 3 min read

The setup: charting course in year two

Milky Mist's debut quarter as a listed company delivered on scale—₹973 Cr revenue (+44% YoY), gross profit ₹333 Cr (34% margin), and PAT ₹65 Cr (+890%, off a thin base from unlisted-period accounting). The Street now watches whether the company can sustain that momentum while integrating ₹40 Cr of newly commissioned manufacturing capacity and scaling premium product lines. Q2 earnings (Oct 29) will be the first read on execution against the 26.5% CAGR guidance DAM Capital flagged for FY26–FY29E.

Expected revenue

~₹320–360 Cr

On-plan growth trajectory; seasonality and new product ramp weigh sequentially

Gross margin target

33–35%

Sustain Q1 level (34%); new high-margin products offset any input-cost drag

EBITDA margin guide

14–15%

Hold Q1 floor (14.9%); capex/absorption impact on opex discipline in focus

Consensus coverage

Thin (1 analyst)

DAM Capital sees 26.5% CAGR to FY29E; one-analyst estimate at ₹175 target (vs. ₹309 price) now appears stale

On track: scale, margin mix, non-South push

Milky Mist entered FY27 with three structural tailwinds. First, pricing power—Q1 gross profit surged 56% on 44% revenue, signalling room to raise prices or shift to higher-margin curd/value-added products. Second, new capacity—the ₹40 Cr Skyr and Greek yogurt plant (live Sep 10) targets the premium yogurt segment (higher-margin, aspirational), while the Oct 15 high-protein milk launch (25g protein, lactose-free, 250 ml pack) taps the health/wellness consumer. Ramp-up speed into Q3–Q4 will be key. Third, geographic reach—management guided to 50% YoY growth in non-South markets; commissioning of solar capacity and visi-cooler rollout (plan: 50,000 units in 3 years) should support branch depth. For Q2 to stay on-plan, volume growth must hold in the core South milk/curd base while new SKUs gain trial.

What the Street says

Operational Impact

Capacity live; ramp profitability and utilization rate critical to Q2–Q3 margins

Three things to watch on Oct 29

1 · Revenue growth trajectory and volume vs. pricing
Did the company sustain 40%+ YoY growth, or has momentum moderated to the 26–30% range? Watch for management commentary on volume (liters/units) vs. pricing power and early demand for high-protein milk. Slowdown would flag execution risk on the 26.5% CAGR guide.
2 · Gross margin and product mix
Can Milky Mist hold the Q1 gross margin (34%) or higher? Watch the mix contribution from Skyr/yogurt (higher-margin) vs. any commodity input-cost pressure in core milk. Margin compression below 32% would concern margin-expansion bulls.
3 · Capex drag and EBITDA sustainability
The ₹40 Cr Skyr plant is live but likely operating below capacity in Q2. Will EBITDA margins hold the 14–15% range, or will depreciation/underabsorption drag the margin down? Any management commentary on payback timeline and utilization ramp would anchor confidence in profitability trajectory.

The bottom line: Milky Mist's listing debut was strong—44% growth, sharp margin expansion, and a clear capex/product strategy to diversify beyond commodity milk. Q2 will test whether new SKUs (high-protein, Skyr/yogurt) ramp fast enough to sustain gross-margin gains while newly commissioned plants absorb capital efficiently. With only one analyst covering the stock and overbought technicals, execution credibility and Q3–Q4 guidance will be critical to justify the premium valuation. Watch volume and pricing health, gross margin resilience, and capex payback confidence as the frame for the print.

Informational and educational content only. Not investment advice.